UA105278C2 - Способ получения каталитически активных антител (абзимов) с сиалидазной активностью - Google Patents

Способ получения каталитически активных антител (абзимов) с сиалидазной активностью

Info

Publication number
UA105278C2
UA105278C2 UAA201210528A UAA201210528A UA105278C2 UA 105278 C2 UA105278 C2 UA 105278C2 UA A201210528 A UAA201210528 A UA A201210528A UA A201210528 A UAA201210528 A UA A201210528A UA 105278 C2 UA105278 C2 UA 105278C2
Authority
UA
Ukraine
Prior art keywords
catalytically
active antibodies
production
sialidase activity
abzymes
Prior art date
Application number
UAA201210528A
Other languages
English (en)
Ukrainian (uk)
Inventor
Ростислав Олександрович Білий
Євгенія Євгенівна Біла
Юрій Ярославович Кіт
Original Assignee
Інститут Біології Клітини Нан України
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут Біології Клітини Нан України filed Critical Інститут Біології Клітини Нан України
Priority to UAA201210528A priority Critical patent/UA105278C2/ru
Priority to PCT/IB2013/001908 priority patent/WO2014037785A2/en
Publication of UA105278C2 publication Critical patent/UA105278C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0002—Antibodies with enzymatic activity, e.g. abzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)

Abstract

Изобретение относится к области иммунологии, клеточной биологии, клинической диагностики, биоорганической химии и может использоваться для создания каталитически активных антител с сиалидазной активностью. Согласно заявленному способу каталитически активные антитела с сиалидазной активностью получают вследствие иммунизации организма конъюгатами гаптена и высокомолекулярного (белкового) носителя, причем как гаптен используют производные ингибитора(ов) сиалидазной реакции.
UAA201210528A 2012-09-06 2012-09-06 Способ получения каталитически активных антител (абзимов) с сиалидазной активностью UA105278C2 (ru)

Priority Applications (2)

Application Number Priority Date Filing Date Title
UAA201210528A UA105278C2 (ru) 2012-09-06 2012-09-06 Способ получения каталитически активных антител (абзимов) с сиалидазной активностью
PCT/IB2013/001908 WO2014037785A2 (en) 2012-09-06 2013-09-05 Catalytic antibodies and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201210528A UA105278C2 (ru) 2012-09-06 2012-09-06 Способ получения каталитически активных антител (абзимов) с сиалидазной активностью

Publications (1)

Publication Number Publication Date
UA105278C2 true UA105278C2 (ru) 2014-04-25

Family

ID=49885295

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201210528A UA105278C2 (ru) 2012-09-06 2012-09-06 Способ получения каталитически активных антител (абзимов) с сиалидазной активностью

Country Status (2)

Country Link
UA (1) UA105278C2 (ru)
WO (1) WO2014037785A2 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4218802A3 (en) * 2016-07-01 2023-09-27 The Board of Trustees of the Leland Stanford Junior University Conjugates for targeted cell surface editing

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS5896026A (ja) 1981-10-30 1983-06-07 Nippon Chemiphar Co Ltd 新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤
CH652145A5 (de) 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4609546A (en) 1982-06-24 1986-09-02 Japan Chemical Research Co., Ltd. Long-acting composition
US4766106A (en) 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
CA1292686C (en) 1986-10-27 1991-12-03 Ze'ev Shaked Pharmaceutical compositions of recombinant interleukin-2 and formulation process
CA1294215C (en) 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
WO1991010448A1 (en) 1990-01-19 1991-07-25 German Cancer Research Center A cell surface antigen associated with cellular apoptosis
US5463028A (en) 1992-04-03 1995-10-31 The Trustees Of Columbia University In The City Of New York Reagents for generating a polyclonal hydrolytic antibody response against cocaine and the monoclonal hydrolytic antibodies against cocaine derived through these reagents
US5770208A (en) 1996-09-11 1998-06-23 Nabi Staphylococcus aureus B-linked hexosamine antigen
US6268488B1 (en) * 1999-05-25 2001-07-31 Barbas, Iii Carlos F. Prodrug activation using catalytic antibodies
FR2825154B1 (fr) * 2001-05-22 2004-01-30 Univ Compiegne Tech Composes capables de moduler l'activite et de stimuler la production d'un anticorps catalytique
WO2003059251A2 (en) * 2001-10-22 2003-07-24 The Scripps Research Institute Antibody targeting compounds
US20030087435A1 (en) 2001-11-06 2003-05-08 Brandt Jeffrey J. Catalytic antibodies raised against sarin; an organophosphorous anticholinesterase, and an antigen and process for the preparation thereof
JP2005530515A (ja) 2002-06-26 2005-10-13 ユニヴァーシティー オヴ ルイスヴィル リサーチ ファウンデイション インコーポレイテッド アポトーシスの検出方法
US20060074047A1 (en) * 2004-10-06 2006-04-06 Cross Alan S Method of treating inflammation with inhibitors of sialyl transferases
WO2007057782A2 (en) 2005-10-11 2007-05-24 Centre National De La Recherche Scientifique (Cnrs) 3 -hydroxyflavone derivatives for the detection and the quantification of cell apoptosis
UA94920C2 (ru) 2005-10-31 2011-06-25 Інститут Біології Клітини Нан України Способ быстрого выявления, выделения и подсчета апоптических клеток, который базируется на агглютинации

Also Published As

Publication number Publication date
WO2014037785A2 (en) 2014-03-13
WO2014037785A3 (en) 2014-05-01

Similar Documents

Publication Publication Date Title
BR112015029009A2 (pt) Anticorpos, ácido nucleico, célula hospedeira, método de produção de anticorpo, formulação farmacêutica e usos de um anticorpo
AR093377A1 (es) Anticuerpos anti-notch y conjugados de anticuerpo-farmaco
AR088322A1 (es) Anticuerpos anti-htra1 y metodos de uso
AR090017A1 (es) Agonistas de fgfr1 y sus metodos de uso
SG10201805291TA (en) Production of heterodimeric proteins
EP2894242A4 (en) POLYMER-METAL COMPLEX CRYSTAL ENVELOPING A CLIENT COMPOUND, METHOD FOR PRODUCING THE SAME, PROCESS FOR PREPARING SAMPLE FOR CRYSTALLINE STRUCTURE ANALYSIS, AND METHOD FOR DETERMINING MOLECULAR STRUCTURE OF ORGANIC COMPOUND
CL2015001088A1 (es) Proceso de elaboración de compuestos derivados de pirimidina (div. sol. 850-13).
EA201490895A1 (ru) Производство сахарного спирта из биомассы
EA201492057A1 (ru) Ферментация и способ с псевдодвижущимся слоем
SG11201403204TA (en) Process for making hmf and hmf derivatives from sugars, with recovery of unreacted sugars suitable for direct fermentation to ethanol
EP2592140A4 (en) SUPPORT FOR IMMOBILIZATION OF A PROTEIN, IMMOBILIZED PROTEIN AND PRODUCTION METHOD THEREOF
AU2012312028A8 (en) Detection of isotype profiles as signatures for disease
BR112014013862A2 (pt) processos incluindo de alta produtividade, para fermentar gás de síntese
EP2580339A4 (en) SYSTEM AND METHOD FOR PRODUCTION OF BIOFUELS
MX366112B (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
EP3074036A4 (en) Preparing antibodies from cho cell cultures for conjugation
DK3342867T3 (da) Xylanasemutant, fremgangsmåde til fremstilling og anvendelse herfor, og fremgangsmåde til fremstilling af forsukret lignocellulose
WO2013068850A3 (en) PROCESS FOR THE PREPARATION OF β-C-ARYL GLUCOSIDES
EP2896694A4 (en) GLUCIDE OXIDASE AND METHOD FOR PRODUCTION AND USE
SG11201505171PA (en) Method for improving yield of enzymatic preparation of biodiesel from greases
IN2014DN09097A (ru)
HK1215244A1 (zh) 用於製備 -溴- -氧雜二環 辛烷- -酮的方法
WO2013162905A8 (en) Methods of producing and using regulatory b-cells
MY164628A (en) Catalytic cracking catalyst
UA105278C2 (ru) Способ получения каталитически активных антител (абзимов) с сиалидазной активностью